|Articles|November 19, 2015
Advanced Clinical Selects TRI RBM Platform
TRI will be providing the OPRA platform for all of Advanced’s studies whose sponsors have requested a risk-based approach to monitoring.
Advertisement
Advanced Clinical, a Chicago-based CRO, has selected Triumph Research Intelligence (TRI) OPRA RBM technology platform and accompanying RBM service offerings. TRI will be providing the OPRA platform for all of Advanced’s studies whose sponsors have requested a risk-based approach to monitoring. TRI will be supporting Advanced in optimizing their monitoring processes, implementing change management, and supporting study specific key risk indicator design.
Read the full
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Quantifying the Net Financial Value of Deploying Risk-Based Quality Management
2
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
3
ACT Brief: Enterprise Risk Management, Execution Architecture for AI, and Rare Pediatric Regulatory Support
4
ACT Brief: Data Pipeline Fragmentation, Vaccine Trial Pressures, and BTK Degrader Partnership
5